Anti-proliferative effect of melissa officinalis on human colon cancer cell line by Encalada, M.A. (Manuel Alejandro) et al.
Anti-proliferative effect of Melissa officinalis on Human Colon Cancer Cell Line 
 
Manuel Alejandro Encaladaa, Kelly Melissa Hoyosa, Sheyla Rehechoa, Izaskun Berasategib, Mikel 
García-Íñiguez de Cirianob, Diana Ansorena b, Iciar Astiasaránb, Íñigo Navarro-Blascoc, Rita Yolanda 
Caverod, María Isabel Calvoa*
 
 
a Department of Pharmacy and Pharmaceutical Technology, Faculty of Pharmacy, University of 
Navarra, Irunlarrea s/n, 31008 Pamplona, Spain 
b Department of Nutrition, Food Science, Physiology and Toxicology, Faculty of Pharmacy, University 
of Navarra, Irunlarrea s/n, 31008 Pamplona, Spain 
c Department of Chemistry and Soil Science, Faculty of Sciences, University of Navarra, Irunlarrea 
s/n, 31008 Pamplona, Spain 
d Department of Plant Biology (Botany), Faculty of Sciences, University of Navarra, Irunlarrea s/n, 
31008 Pamplona, Spain 
 
*Corresponding address: Department of Pharmacy and Pharmaceutical Technology, School of 
Pharmacy, University of Navarra, C/ Irunlarrea s/n, 31080 Pamplona, Spain. e-mail: mcalvo@unav.es
Abstract 
Melissa officinalis L. (Lamiaceae) is consumed as a traditional herbal tea in the Mediterranean 
region. The cytotoxic effect of the 50% ethanolic and aqueous extract, determined by the MTT and 
NR assays, was evaluated in vitro on Human Colon Cancer Cell Line (HCT-116), using Triton 10% 
as positive control. The 50 % ethanolic extract showed significant differences after 72 hours of 
treatment, reducing cell proliferation to values close to 40%, even the lowest dose tested (5 μg/ml). 
In the MTT assay, the same extract caused the lowest cell viability with 13% at a concentration of 
1000 μg/ml after 72 h of treatment, being a value lower than triton 10%. The antioxidant activity 
was also confirmed evaluating the capacity of the extracts to scavenge ABTS and DPPH radicals, 
and IC50 values were highly correlated with the total phenolic and flavonoid content. Bioassay 
guided fractionation led to the isolation of an anti-proliferative compound, rosmarinic acid. Its 
structural elucidation was performed by HPLC/DAD/ESI/MS analysis. High dose of rosmarinic 
acid (1000 μg/ml) was clearly cytotoxic against HCT-116 cells, with a significant decrease in cell 
number since the earliest time point (24 h). 
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Abbreviations:  
AQE: Aqueous extract 
HAE: 50% ethanolic extract 
RA: Rosmarinic acid 
TFC: Total flavonoid content 
TPC: Total phenolic content 
 
Introduction 
Cancer is one of the major human diseases and causes considerable suffering and economic loss 
worldwide. Colorectal cancer (CRC) with 655,000 deaths worldwide per year, it is the fourth most 
common form of cancer in the United States and the third leading cause of cancer-related death in the 
Western world [1]. Therefore, further research is needed for the development of safe products for the 
prevention and treatment of all human cancers. Approximately 60% of drugs currently used for cancer 
treatment have been isolated from natural products [2] and the plant kingdom has been the most 
significant source. These include Vinca alkaloids, Taxus diterpenes, Camptotheca alkaloids, and 
Podophyllum lignans. Currently, there are 16 new plant-derived compounds being tested in clinical 
trials and of these 13 are being tested in phase I or II, and 3 are in phase III. Among these compounds, 
flavopiridol, isolated from the Indian tree Dysoxylum binectariferum, and mesoindigo, isolated from 
the Chinese plant Indigofera tinctoria, have been shown to exhibit anti-cancer effects with lesser 
toxicity than conventional drugs [3]. 
Epidemiological studies, experiments on laboratory animals and investigations of humans show 
that consumption of a diet rich in vegetables and fruits is associated with a low risk of some diseases 
including cardiovascular diseases and cancer. This beneficial effect has been attributed to the bioactive 
compounds of these natural products and first of all to phenolic compounds, due to their ability to act 
as efficient free radical scavengers. Many plants possess antioxidant activities and their consumption 
was recommended [4, 5]. Therefore, the phytochemicals present in herbal products, marketed as 
dietary supplements, may act as preventative or therapeutic agents similar to over-the counter (OTC) 
and prescription drugs. 
Lemon balm, M. officinalis L. is one of the most used medicinal plants in Europe and the 
Mediterranean region, as a herbal tea for their aromatic, digestive and antispasmodic properties in 
nervous disturbance of sleep and functional gastrointestinal disorders [6]. The leaves emit a distinct 
fragrant lemon odour when bruised. The chemical composition is essential oil, polyphenolic 
compounds: caffeic acid derivatives in large proportions, such as RA, trimeric compounds, and also 
some flavonoids such as luteolin-7-0-glucoside. Some pharmacological properties have been attributed 
to the principal constituents. Essential oil is considered to be the therapeutic principle mainly 
responsible for most of the activities mentioned, spasmolytic, antimicrobial, antitumor and antioxidant, 
mainly [7]; but plant phenolics, especially RA, are involved too. Enriched extracts containing RA are 
used as a virostatic against herpes viruses, alcohol extracts as sedatives and the essential oil as a 
digestive aid in pharmaceutical preparations [8]. Moreover, its neuroprotective properties have been 
demonstrated using an in vitro cellular model with the PC12 (rat pheochromocytoma) cell line, as well 
as its neurological activities with methanolic extracts being more effective than aqueous extracts [9]. 
In the course of our interest in biological and industrial applications from this plant [9-12], this 
paper focuses on the analysis of the anti-proliferative activity of M. officinalis extracts, fractions and 
RA. In-vitro cytotoxicity analysis, using MTT and NR assays, indicated that this plant was very 
effective against human colon cancer cell line (HCT-116). These results pointed to the potential use of 
M. officinalis as an anti-cancer agent. 
 
Material and Methods 
Chemicals 
Cell culture products as well a media were obtained from Gibco (Barcelona, Spain). Chemical reagents 
were purchased from Sigma-Aldrich (Spain). RA (purity ≥ 99%) was obtained form Extrasynthèse 
(Genay, France).  
 
Preparation of Extracts 
M. officinalis dried leaves were purchased from Plantarom S.L. (Barcelona, Spain). 50% ethanolic 
(HAE) and aqueous (AQE) extracts of plant were prepared [11]. Both extracts presented a very similar 
percentage of extraction (HAE: 23.01%; AQE: 21.76% dry weight base). 
 
Determination of the scavenging activity, total phenolic (TPC) and flavonoid (TFC) content 
Two different methods were used for the evaluation of the antioxidant activity: DPPH radical 
scavenging assay [13], and 2,2-azinobis-(3-ethylbenzthiazoline-6-sulphonic acid (ABTS) assay [14]. 
The results were compared with BHT and BHA, two of the most usually used synthetic antioxidants. 
The antioxidant activity was expressed as IC50 values, which were calculated by non-linear regression 
with a one phase exponential association equation using GraphPad Prism version 4.0. 
 TPC and TFC of samples were quantified spectrophotometrically according to the published 
procedures [15, 16]. All determinations were carried out in triplicate and the mean values were used. 
 
Determination of the cytotoxicity in HCT-116 cells (Human Colorectal Carcinoma Cells) 
Cell Culture 
HCT-116 cells were obtained from the American Type Culture Collection. Cells were grown in 
Dulbecco’s modified eagle’s medium (DMEM) supplemented with 10% heat-inactivated fetal bovine 
serum (FBS), penicillin (10 U/ml), streptomycin (10 μg/ml) and 0.2 mM sodium pyruvate. Cultures 
were incubated in the presence of 5% CO2 at 37 °C and 100% relative humidified atmosphere. 
Determination of Cell Survival by the MTT Reduction Assay 
HCT-116 cells were seeded in 96-well microplates at a density of 10×103 cells/well and grown for 24 
h at 37 °C in 5% CO2 prior to the addition of test samples. Cells were treated with various 
concentrations of samples (5-1000 μg/ml) dissolved in Dulbecco’s phosphate buffered saline (PBS). 
After 24, 48 and 72 h of incubation, cell viability was determined using the colorimetric MTT assay. 
MTT solution at 5 mg/ml was dissolved in 1 ml of PBS, and 200 μL of it was added to each of the 96 
wells. The wells were wrapped with aluminium foil and incubated at 37 ºC for 90 minutes. The 
solution in each well containing media, unbound MTT and dead cells were removed by suction and 
100 μL of DMSO was added to each well. Then the plates were shaken and cell survival (%) was 
measured as reduction of MTT into formazan at 550 nm. 10 μL of 10% Tritón® X-100 solution was 
used as positive control, because in biological research, this detergent is used for lysing cells. 
Untreated cells (at 0 μg/ml, vehicle alone) were chosen as the negative control Controls and samples 
were assayed in triplicate for each concentration and replicated three times. The absorbance values 
were converted into percentages of cell viability using the following formula: Cell viability (%) = (Abs 
sample / Abs control) x 100 
Neutral Red (NR) Assay 
5 x 103 cells were plated in 96-well microplates and incubated at 37 °C in 5% CO2. After 24 h, cells 
were treated with various concentrations of samples (5-1000 μg/ml) dissolved in PBS. After 24, 48 and 
72 h of incubation, cell viability was determined using the colorimetric NR assay. Neutral red solution 
at a final concentration of 50 μg/ml in culture medium and 200 μL of it was added to each of the 96 
wells. The wells were wrapped with aluminium foil and incubated at 37 ºC for 90 minutes. The 
solution in each well containing media, unbound NR and dead cells were removed by suction and with 
100 μL of a mixture with 1% formaldehyde-1% CaCl2 and the dye extracted with 0.2 ml of 1% acetic 
acid in 50% ethanol was added to each well. Then the plates were shaken and cell survival (%) was 
measured at 540 nm. The absorbance values were converted into percentages of cell viability using the 
same formula as for the MTT assay. 
 
Bioassay-guided fractionation and isolation of cytotoxic and antioxidant compound 
A multi-step fractionation procedure was carried out in order to separate the different constituents of 
the HAE, using Sephadex LH-20 as stationary phase About 3.5 g of HAE, was dissolved in 2 ml of 
50% ethanol and chromatographic separation was achieved with 50% ethanol as mobile phase, 
yielding six fractions (F1: 0.45 g; F2: 1.74 g; F3: 0.61 g; F4: 0.27 g; F5: 0.47 g; F6: 0.31 g). F5 
showed antioxidant and antiproliferative activity and 0.31 mg of the active compound from this 
fraction (1) was isolated by preparative reversed-phase HPLC, using water (85%) and acetonitrile 
(15%) as eluents. The purity of peak 1 (>95%) was checked by a Diode Array Detector coupled to the 
HPLC system, and the identification was performed by HPLC-DAD, HPLC-MS comparing the 
isolated compound with authentic reference sample or data reported in the literature. 
 
HPLC-DAD and HPLC-MS Analysis 
The extracts and fractions were analyzed by HPLC using a Waters (Milford, MA, USA) 600E multi-
solvent delivery system, a Waters U6K sampler and a Waters 991 photodiode-array detector. 
Chromatography was performed on a C18 reversed-phase column (Nova-Pak, 150 mm x 3.9 mm., 4 
μm, Waters) at 25ºC. Detection was a range between 210-500 nm. The mobile phase was formed by 
acetonitrile (A) and twice distilled water adjusted to pH 3 with acetic acid (B) in different proportions. 
The elution system was: 0-1 min, 93-90% of B; 1-5 min, 90% of B; 5-8 min, 90-85% of B; 8-13 min, 
85% of B; 13-30 min, 85-40% of B and 30-40 min, 40% of B. The flow rate employed was 1 ml/min. 
HPLC-MS analysis was performed using a HP 1100L liquid chromatograph linked to a HP 100 MSD 
mass spectrometer with an API/electrospray interface (Agilent Technologies, Palo Alto, CA, USA). 
The column, time period and flow rate were similar to those used during the HPLC-DAD analysis. The 
mass spectrometer operating conditions were: gas temperature, 350 ºC; nitrogen flow rate, 10 L/min; 
nebulizer pressure 30 psi; quadrupole; temperature, 25 ºC; capillary voltage, 3500 V. The mass 
spectrometer was operated in positive and negative mode at 12 eV. 
 
Statistical Analysis 
Data are mean±SD of three independent experiments. Cell assays were analyzed by ANOVA followed 
by Dunnett´s test whereas IC50 values were analyzed by Student test. 
 
Results and Discussion 
Botanicals and plant foods are also a source of antioxidants, which play a special role in 
chemoprevention. In fact, plant extracts and isolated compounds are formulated in a great variety of 
dietary supplements regarding antioxidant and protective effects against ROS, of which an excess is 
associated with ageing, cataracts, cardiovascular and neurodegenerative diseases and certain types of 
cancer. The antioxidant activity was evaluated in different in vitro models (Table 1). The antioxidant 
capacity is described quantitatively by the concentration of antioxidant needed to scavenge 50% of 
either DPPH• or ABTS•+ which is referred to as the IC50. The IC50 was obtained from the graph of the 
percentage of scavenged radical versus the concentration of antioxidant. Both DPPH• and ABTS•+ 
radicals have been widely used to investigate the ability of plant extracts and fractions and/or pure 
compounds of those, to act as free radical-scavengers or hydrogen donors. Both extracts tested in this 
work were capable of scavenging DPPH• radicals. Activity of HAE (IC50=11.04±0.72 μg/ml) and 
AQE (IC50=17.11±1.70 μg/ml) demonstrated a higher scavenging capacity compared to other 
medicinal plants previously analyzed [10, 13]. The ABTS•+ assay, revealed similar results as the 
DPPH• assay (8.60±1.48 and 9.22±1.28 μg/ml, respectively). Extremely high and negative correlation 
(*P<0.01) was observed between TPC and IC50 for DPPH• radical scavenging activity (r2=-0.955), 
and ABTS•+ radical scavenging activity (r2=-0.967). Results also showed that TFC had high and 
statistically significant negative correlation (**P<0.05) with DPPH• radical scavenging activity (r2=-
0,885) and ABTS•+ radical scavenging activity (r2=-0.863). Therefore, good correlation suggests that 
phenolic compounds, no only flavonoid type, play an important role as antioxidants. In the same way, 
various studies correlating lemon balm’s medicinal properties with its antioxidant activity and phenolic 
profile have been published. Despite, the usage of various methods for the evaluation of antioxidant 
capacity makes comparison even more difficult, the same results have been found by other authors; it 
was previously reported that aqueous methanolic extract of M. officinalis caused a concentration-
dependent inhibition of lipid peroxidation, and phenolic components present demonstrated antioxidant 
activity [17]. Hydroalcoholic extracts have also shown significant antioxidative activities, by free 
radical scavenger effect on DPPH, partly in relation to their RA content [18]. 
The initial screenings for plants used for cancer treatment are cell-based assays using 
established cell lines, in which the toxic effects of plant extracts or isolated compounds can be 
measured. Cytotoxic screening models supply important preliminary data to select plant extracts or 
compounds with potential antineoplastic properties. In addition, cytotoxic assays do not provide false 
negative results since they consider plant extracts or compounds which affect cell viability. In this 
paper, the HAE and AQE were tested on HCT-116 tumour cell lines by the tetrazolium MTT and the 
neutral red (NR) assays. The NR assay is based on the uptake of neutral red, a supravital dye, and its 
accumulation in the liposome of viable uninjured cells, and it is based on the reduction of the soluble 
yellow MTT tetrazolium salt (purple compound) to a blue insoluble MTT formazan product by 
mitochondrial succinic dehydrogenase [19]. Various studies demonstrate that both the NR and MTT in 
vitro cytotoxicity assays can be applied to screening the acute toxicities of compounds and to 
identifying interactions when combinations of them are used [20]. The good agreement (r=0.939) 
between the ranking of the values of both methods suggests that although each test has a different 
physiological endpoint, the assays yield comparable data. Conversely, the differential sensitivities 
between the NR and MTT assays for some antineoplastic drugs might prompt the inclusion of both 
assays in a battery of test methods. The cell proliferation inhibition was registered at six different doses 
and three times (Fig. 1). The profile of results obtained by the MTT and NR assays for both extracts 
was similar. In the case of AQE, significant (P<0.05) or very significant (P<0.01) differences were 
found in comparison to negative control at higher doses tested (1000 μg/ml), reaching values similar to 
triton (positive control), after 24, 48 and 72 h of treatments (Fig. 1a-b). Figure 1d shows that HAE 
showed significant differences after 72 hours of treatment, reducing cell proliferation to values close to 
40%, even the lowest dose (5 μg/ml). In the MTT and NR assays; the HAE extract caused the lowest 
cell viability with 13% at a concentration of 1000 μg/ml after 72 h of treatment, being a value lower 
than triton 10% (Fig. 1c-d). Recently, many plant extracts and natural products, especially phenolics, 
with high antioxidant activity have shown antiproliferative effects in different cell lines including NCI-
H82 (human, small cell lung, carcinoma), DU-145 (human, prostate, carcinoma), Hep-3B (human, 
black, liver, carcinoma, hepatocellular), K-562 (human chronic myeloid leukemia), MCF-7 (human, 
breast, adenocarcinoma), PC-3 (human, prostate, adenocarcinoma) and MDA-MB-231 (human, breast, 
adenocarcinoma) [21, 22]. Fractionation of the HAE by Sephadex LH-20 CC yielded six fractions. The 
antioxidant activity evaluation tests of the fractions showed that, the most active fractions were F5 
against DPPH radical and ABTS•+ assay (1.84±0.06 and 4.44±0.25 μg/ml, respectively) (Table 1). The 
same correlations were also obtained between TPC and TFC with antioxidant activity. In cell viability 
assays, fraction F5 was also the most active against the HCT-116 cell line at 1000 μg/ml, 24, 48 and 72 
hours after treatment (Fig. 2). As can be seen the percentages obtained are similar to triton. 
The HPLC-DAD analysis of fraction F5 revealed the presence of a main compound (1) (95% of 
the composition) and several small peaks in less proportion (5%). The active compound (1) of this 
fraction was isolated by preparative reversed-phase HPLC and the structure was elucidated as an ester 
of caffeic acid and 3-(3,4-dihydroxyphenyl)lactic acid, rosmarinic acid [23]. Compound 1 was 
obtained as a finely crystalline light yellow, mp 165-174 ºC (dec.), [α]D20 -32.5 º (c 0.05, MeOH), m/z = 
360.08 [M]+. The UV absorbance maximum at 327 nm and a shoulder at 290 nm indicate the nature of 
phenolic acid with two aromatic rings. These observations were confirmed by the LC-MS analyses of 
compound 1, where the most important ion fragmentations were m/z = 359.07 [M-H]-, 197.04 [M-H-
162]-, 179.03 [M-H-180]-, 161.02 [M-H-198]-, corresponding to the deprotonated form of 3-(3,4-
dihydroxyphenyl)lactic and caffeic acids and their dehydrated forms. RA is a polyphenolic compound 
present in high amount in many herbal plants of the Lamiaceae family such as rosemary, lemon balm, 
sage, oregano or savory. There is consensus that the significant antioxidant properties by lemon balm 
are mainly due to the large quantities of RA [24]. Several biological activities have been described for 
RA in relation to its antioxidant activity, the most known being anti-inflammatory, antiviral, 
antimicrobial, neuroprotective and neurological properties, and anticancer against various cell lines [9, 
25-28]. However, this study is the first to establish a relationship between the antioxidant activity of 
RA and this celll line. HCT-116 cells were treated with RA (5-1000 μg/ml) for 24, 48 and 72 h, and as 
shown in Table 2, high dose was clearly cytotoxic, with a significant decrease in cell number since the 
earliest time point (24 h). 
In conclusion, the results of this study have shown a high correlation between the phenolic 
content, antioxidant effect and antiproliferative activity in extracts and fractions. For this reason, RA 
could contribute, at least in part, induced cytotoxic effect in this cell line. Future research would be 
needed to determine the chemical nature of other compounds present in lemon balm, and possible 
synergism of action with RA. Considering our results along with the preliminary studies, we suggest 
that RA in combination with the anticancer drugs may offer a good strategy for the treatment of a 
human colon cancer. 
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 Table 1. Total phenol and flavonoids, antioxidant activity of Melissa officinalis extracts and fractions. 
 








AQE 1980.54 ± 162.22 672 ± 0.04 17.11 ± 1.70 9.22 ± 1.28 
HAE 3407.32 ± 360.47 927 ± 0,08 11.04 ± 0.72 8.60 ± 1.48 
F1 33.72 ± 2.71 <0.5 218.43 ± 0.85 > 500 
F2 399.70 ± 10.52 33.48 ± 1.87 37.96 ± 1.27 63.98 ± 5.14 
F3 846.42 ± 9.55 78.70 ± 2.34 3.39 ± 0.07 8.30 ± 0.73 
F4 196.90 ± 5.01 87.65 ± 3.46 7.13 ± 0.09 13.38 ± 0.81 
F5 1423.93 ± 142.33 269.48 ± 9.29 1.84 ± 0.06 4.44 ± 0.25 
F6 178.32 ± 2.65 97.58 ± 3.12 8.62 ± 0.14 21.79 ± 2.47 
BHA - - 3.88 ± 0.72 2.79 ± 0.13 
BHT - - 5.05 ± 0.63 5.22 ± 0.75 
 
Table 2. Percent cell survival of rosmarinic acid (1) against HCT-116 colon human tumour cell lines. 
 
   Time (hour)  
Doses (μg/ml) Method 24 h 48 h 72 h 
5 MTT 76.47 ± 5.41 75.24 ± 6.53 65.32 ± 7.51 
 NR 75.50 ± 9.74 6.217 ± 5.59 65.19 ±9.16 
500 MTT 70.59 ± 2.97 60.70 ± 5.77 58.87 ±9.30 
 NR 74.17 ± 5.12 45.01 ± 3.26 62.11 ± 7.15 
1000 MTT 19.36 ± 5.07 18.82 ± 3.56 18.30 ±2.98 
 NR 14.84 ± 4.15 10.46 ± 1.87 10.17 ± 2.03 
C(+) MTT 20.14 ± 7.09 19.39 ± 3.45 19.55 ± 4.32 
 NR 10.40 ± 2.11 10 ± 2.57 10 ± 1.99 
C(-)   100± 0.00  
 
 
  
 
